Viral infections and wheezing–asthma inception in childhood: is there a role for immunomodulation by oral bacterial lysates?

• Review
• Open Acces

• Giovanni A. Rossi, 
• Petr Pohunek, 
• Wojciech Feleszko, 
• Stefania Ballarini & 
• Andrew A. Colin 

Clinical and Translational Allergy volume 10, Article number: 17 (2020) 

• details

Abstract

Severe and recurrent infections of the respiratory tract in early childhood constitute major risk factors for the development of bronchial hyper-responsiveness and obstructive respiratory diseases in later life. In the first years of life, the vast majority of respiratory tract infections (RTI) leading to wheezing and asthma are of a viral origin and severity and recurrence are the consequence of a greater exposure to infectious agents in a period when the immune system is still relatively immature.

Therefore, boosting the efficiency of the host immune response against viral infections seems to be a rational preventative approach. In the last decades it has been demonstrated that living in farm environments, i.e. early-life exposure to microbes, may reduce the risk of allergic and infectious disorders, increasing the immune response efficacy. These findings have suggested that treatment with bacterial lysates could promote a nonspecific immunomodulation useful in the prevention of recurrent RTIs and of wheezing inception and persistence. Experimental and clinical studies showing the reduction of RTI frequency and severity in childhood and elucidating the involved mechanisms can support this hypothesis.

Download PDF